PPARG and coronary artery disorder: The Ala 12 Ala genotype of the PPARγ2 may decrease the number of diseased vessels and the severity of CAD, which could be because of a direct anti-atherogenic effect of this polymorphism as well as an indirect effect through its association with a lower level of inflammatory parameters and IR [56].